T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer|Sarcoma|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: trastuzumab
Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)